Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.
Friday 19 October 2018
Biliary Tract Cancer: Current Status & Future Prospects
Friday, 18:00 - 20:00
View the satellite invitation
Checkpoint Inhibition in the Treatment of Cancer: Building the New Standard of Care Across Multiple Solid Tumors and Understanding the Role of Pembrolizumab
Friday, 18:00 - 20:00
View the satellite invitation
Comprehensive Genomic Profiling: Taking Precision Medicine from Vision to Reality
Friday, 18:00 - 20:00
View the satellite invitation
Immunotherapy in Daily Clinical Practice: Clinical Application and Emerging Opportunities
Friday, 18:00 - 20:00
View the satellite invitation
Navigating New Waters in mRCC
Friday, 18:00 - 19:30
View the satellite invitation
Precision Medicine in Oncology Care: Using Every Available Tool
Friday, 18:00 - 19:30
View the satellite invitation
The Future Is Now: Innovations in I-O for First-Line Advanced Renal Cell Carcinoma
Friday, 18:00 - 20:00
View the satellite invitation
The Path to Precision Medicine—Accelerating Science and Evolving Oncology Treatment Paradigms
Friday, 18:00 - 20:00
View the satellite invitation
The Rise in Oncology Biosimilars: From Process to Promise
Friday, 18:00 - 20:00
View the satellite invitation
Transforming the Treatment Paradigm in Gastrointestinal Cancers with Immuno-Oncology
Friday, 18:00 - 20:00
View the satellite invitation
Trastuzumab Biosimilar for Tomorrow
Friday, 18:00 - 20:00
View the satellite invitation
Women for Mankind: Optimal Use of Chemotherapy in Metastatic Prostate Cancer
Friday, 18:00 - 20:00
View the satellite invitation
Saturday 20 October 2018
Considerations as We Treat mCRPC Earlier
Saturday, 13:00 - 14:30
View the satellite invitation
Global Perspectives on Optimal Treatment for HR+, HER2– Advanced Breast Cancer
Saturday, 13:00 - 14:30
View the satellite invitation
HER2 Expression in Metastatic Breast Cancer: A Paradigm Shift?
Saturday, 13:00 - 14:30
View the satellite invitation
Looking Beyond the Obvious in Management of Advanced RCC
Saturday, 13:00 - 14:30
View the satellite invitation
Mapping the Optimal Treatment Sequence in mCRC
Saturday, 13:00 - 14:30
View the satellite invitation
Setting a New Standard of Care in Advanced Lung Cancer
Saturday, 13:00 - 14:30
View the satellite invitation
Treating Pretreated mCRC and mGC: Management Strategies for Better Patient Outcomes
Saturday, 13:00 - 14:30
View the satellite invitation
Optimizing Evidence-Based Treatment Planning with Multikinase Inhibition in mCRC and uHCC
Saturday, 18:30 - 20:00
View the satellite invitation
Prediction with Precision: Does TAILORx Make Chemotherapy a Personalized Treatment?
Saturday, 18:30 - 20:00
View the satellite invitation
The Evolving Landscape of Treating Cancer-Associated Thrombosis (CAT): From LMWH to Direct Oral Anticoagulants (DOACs)?
Saturday, 18:30 - 20:00
View the satellite invitation
Scaling New Heights in Breast Cancer Care
Saturday, 18:30 - 20:00
View the satellite invitation
Sunday 21 October 2018
CDK Inhibitor Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer Clinical Characteristics and Choices
Sunday 13:00 - 14:30
View the satellite invitation
EGFR-Mutated NSCLC: A Data-Driven Approach to Optimising Patient Outcomes
Sunday, 13:00 - 14:30
View the satellite invitation
Is Earlier Better? Translating Clinical Evidence into Individualised Treatment Decisions in Advanced Prostate Cancer
Sunday, 13:00 - 14:30
View the satellite invitation
New Options for HER2+ Breast Cancer: Building on Success
Sunday, 13:00 - 14:30
View the satellite invitation
PARP Inhibitors: Opening the Door to New Treatment Options in Recurrent Ovarian Cancer
Sunday, 13:00 - 14:30
View the satellite invitation
Treating Lung Cancer in a Rapidly Evolving Landscape
Sunday, 13:00 - 14:30
View the satellite invitation
Expanding Horizons in Lung Cancer Treatment: New Data and Emerging Biomarkers
Sunday, 18:30 - 20:00
View the satellite invitation
Getting the Best Out of Targeted Therapies for ALK+ NSCLC: Practical Insights on Choices and Trade-Offs
Sunday, 18:30 - 20:00
View the satellite invitation
Navigating the Treatment Sequence for Patients Living with Nets. Do You Have Enough Evidence to Support Clinical Decisions?
Sunday, 18:30 - 20:00
View the satellite invitation
Sequencing Life-Prolonging Agents in Prostate Cancer
Sunday, 18:30 - 20:00
View the satellite invitation
Monday 22 October 2018
Changing the Natural Disease Course in Ovarian Cancer: The Role of PARPi Maintenance
Monday, 13:00 - 14:30
View the satellite invitation
Changing the Natural History of Breast Cancer: Where are We, and What’s Next in HER2-Positive and Triple-Negative Disease?
Monday, 13:00 - 14:30
View the satellite invitation
From Early to Advanced Melanoma: An Oncologist’s View of Systemic Treatment Opportunities
Monday, 13:00 - 14:30
View the satellite invitation
From Revolution to Evolution: What’s Next for Checkpoint Inhibition in Solid Tumours?
Monday, 13:00 - 14:30
View the satellite invitation
How Do We Improve Treatment Outcomes of Patients with BRAF-Positive Metastatic Melanoma?
Monday, 13:00 - 14:30
View the satellite invitation
How Immunotherapy is Revolutionising First-Line Lung Cancer Care
Monday, 13:00 - 14:30
View the satellite invitation
Maximising Patient Outcomes Through Evidence-Based Decision-Making in Advanced Gastric and GEJ Cancer
Monday, 13:00 - 14:30
View the satellite invitation
Joining Together to Improve Overall Survival in Oncogenic-Driven NSCLC
Monday, 13:00 - 14:30
View the satellite invitation
Biomarkers in Lung Cancer: Targeting the Right Patient with the Right Therapy
Monday, 18:30 - 20:00
View the satellite invitation
Evolution of Immunotherapy and the Road Ahead in HNSCC
Monday, 18:30 - 20:00
View the satellite invitation
Innovative Targeted Therapies in NSCLC and Beyond
Monday, 18:30 - 20:00
View the satellite invitation
PARP Inhibition in Ovarian Cancer: Is it Time for a Paradigm Shift?
Monday, 18:30 - 20:00
View the satellite invitation
Precision Immuno-Oncology: Driving Patient Selection and Clinical Care Through Biomarker Testing
Monday, 18:30 - 20:00
View the satellite invitation
Treating Cancer-Associated Thrombosis Today New Concepts and Perspectives
Monday, 18:30 - 20:00
View the satellite invitation
Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.
View the Complete ESMO 2018 Industry Satellite Symposia Programme